After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ANRO belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. The current market capitalization of Alto Neuroscience Inc is $84.69M. A total of 2.41 million shares were traded on the day, compared to an average of 259.10K shares.
In the most recent transaction, Savitz Adam bought 12,069 shares of ANRO for 12.60 per share on Jul 09 ’24. After the transaction, the CHIEF MEDICAL OFFICER now owns 36,920 company shares. In a previous transaction on Jul 10 ’24, Savitz Adam bought 2,931 shares at 13.22 per share. ANRO shares that CHIEF MEDICAL OFFICER owns now total 39,851.
Among the insiders who bought shares, Smith Nicholas Conrad acquired of 6,150 shares on Mar 28 ’24 at a per-share price of $16.36. This resulted in the CHIEF FINANCIAL OFFICER holding 26,866 shares of ANRO after the transaction.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ANRO in the last 3 months, the mean price target is $11.69 with high estimates of $18.00 and low estimates of $4.00. In terms of 52-week highs and lows, ANRO has a high of $18.35 and a low of $2.67.
As of this writing, ANRO has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ANRO’s latest balance sheet shows that the firm has $25.70M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $1.81M in liabilities at the time. Its Book Value Per Share was $6.12, while its Total Shareholder’s Equity was -$12.48M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ANRO is Buy with a score of 4.50.
